TRAVERE THERAPEUTICS, INC.

Entity uei:JUBZMHK84S36 · UEI JUBZMHK84S36

About this data

Bounded ingest, not a census: 20,977 contract awards currently loaded (1,294 with full transaction history), per the scope in outlay.config.json. Totals are totals of the ingested set.
Dollar amounts are obligations — money the government has promised to pay, not cash already out the door. Agencies report this data themselves; the Defense Department publishes ~90 days late; the current budget year is still in progress. See methodology.
Source records republish silently; Outlay keeps its own append-only version archive from first pull onward. Post-publication revisions recorded so far: 0 awards (0 revisions). Revisions are routine (spending progresses, errors get corrected) and are not themselves evidence of anything.

Last ingest run #11 (failed) started Aug 5, 2026, 07:42 UTC — 0 awards, 0 details, 0 transactions.

Obligations by fiscal year

$437K

$213K

$132K

Awards (4)


36C25024P0081 ↗ CHENODAL 250MG (CHENODIOL) PHARMACEUTICAL	Department of Veterans Affairs Department of Veterans Affairs	FY2024	Oct 10, 2023 – Sep 30, 2024	$237K	—
36C25025P0025 ↗ PHARMACEUTICAL DRUG	Department of Veterans Affairs Department of Veterans Affairs	FY2025	Oct 1, 2024 – Sep 30, 2025	$213K	—
36C25024P0819 ↗ CHENODAL 250MG (CHENODIOL) PHARMACY	Department of Veterans Affairs Department of Veterans Affairs	FY2024	Apr 1, 2024 – Mar 31, 2025	$201K	—
36C26226N0373 ↗ EMERGENCY THIOLA 100 MG TABLETS	Department of Veterans Affairs Department of Veterans Affairs	FY2026	Feb 10, 2026 – Feb 9, 2027	$132K	—

Raw recipient names from source records that resolved to this entity.